Why MedTech companies are rethinking the ‘house of brands’ model

Many MedTech companies are rethinking the house of brands model as portfolios become more complex through platforms, digital ecosystems, and long-term partnerships. A stronger masterbrand can help scale trust across the portfolio, simplify complexity, and support adoption of new technologies and services.